Jafron Biomedical Co (SZSE:300529) EPS (Basic) : ¥0.93 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co EPS (Basic)?

Jafron Biomedical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.23. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.93.

Jafron Biomedical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.91.

Jafron Biomedical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.22. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.91.

During the past 12 months, Jafron Biomedical Co's average EPS without NRIGrowth Rate was 36.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -10.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Jafron Biomedical Co's highest 3-Year average EPS without NRI Growth Rate was 49.50% per year. The lowest was -19.60% per year. And the median was 16.20% per year.

Jafron Biomedical Co EPS (Basic) Historical Data

The historical data trend for Jafron Biomedical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jafron Biomedical Co EPS (Basic) Chart

Jafron Biomedical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

1.10

1.49

1.12

0.55

1.05

Jafron Biomedical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.35	0.34	0.30	0.06	0.23

Jafron Biomedical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jafron Biomedical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(820.195	-	0)	/	781.139
	=	1.05

Jafron Biomedical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(188.784	-	0)	/	810.926
	=	0.23

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.93

Jafron Biomedical Co (SZSE:300529) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Jafron Biomedical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jafron Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085

Website

http://www.jafron.com

Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.

Executives

Li Feng	Director
He Xiao Lian	Executives
Dong Fan	Directors, Directors, and Executives
Ceng Kai	Directors, executives
Tang Xian Min	Directors, executives
Zhang Ming Yuan	Secretary Dong
Fang Li Hua	Supervisors
Zhang Guang Hai	Directors, executives
Li De Zhi	Executives
Lu Shao Zhang	Executives

Jafron Biomedical Co Headlines

No Headlines